About 976,000 results
Open links in new tab
  1. Association of Chronic Proton Pump Inhibitor Use in Lung Transplant ...

    We aimed to assess whether chronic PPI use in lung transplant recipients is associated with benefits in long-term outcomes, specifically chronic lung allograft dysfunction (CLAD) and …

  2. Proton Pump Inhibitors Independently Protect Against Early …

    Post-lung transplant exposure to persistent PPI therapy results in the greatest protection against rejection in lung transplant recipients, independent of other clinical predictors including BMI, …

  3. Lung transplantation: General guidelines for recipient selection

    An overview of lung transplantation, the international guidelines for recipient selection, disease-specific indications, and choice of procedure are presented separately.

  4. Standardized Anti-Reflux Protocol for Lung Transplant Candidates

    Mar 27, 2023 · Proton pump inhibitors (PPIs) were not prescribed routinely after transplantation. They were given for any reflux-associated symptoms or if the patient had evidence of objective …

  5. Proton Pump Inhibitors Independently Protect Against Early …

    AIMS: To assess the relationship between post-transplant acid suppression with proton pump inhibitors (PPI) or histamine-2 receptor antagonists (H2RA) and onset of early allograft injury …

  6. Acid Suppression Results in a Decrease in Mortality for GERD …

    May 21, 2022 · “Acid suppression therapy with PPI or H2RA after lung transplantation was independently associated with decreased 1-year mortality,” the authors wrote. “These findings …

  7. Benefit and Safety of Long-Term Proton Pump Inhibitor Use in Lung ...

    Recent studies have raised concerns over the safety of long-term PPI use, including potentially increased risk of pneumonia. In view of this, we assessed long-term PPI use and association …

  8. Research Into the Effect of Proton Pump Inhibitors on Lungs and ...

    Animals in the second group (PPI group) were administered a single dose of ip PPI (pantoprazole 40 mg vial, Sandoz/Turkey) in a volume of 0.1 cm 3, 0.6 mg/kg dose every day for 30 days …

  9. Kaplan–Meier curves demonstrating that persistent PPI use was...

    A retrospective review of persistent PPI therapy in 188 patients post lung transplant demonstrated that PPIs are protective against rejection, independent of other clinical predictors...

  10. Long-term Outcomes of Lung Transplant With Ex Vivo Lung

    Oct 9, 2019 · This cohort study assesses the long-term outcomes of transplant recipients of donor lungs treated with ex vivo lung perfusion.